In Kerala, outdoor workers are being diagnosed with cataract earlier than expected, raising questions about ultraviolet exposure, coastal geography and gaps in eye care.
W hen diagnosed with diabetic macular edema (DME) in 2017, Sarah Castaneda, 41, thought she would lose her eyesight completely. At least, that’s what her doctor told her would happen if she didn’t ...
SAN FRANCISCO — A 2-year-old wolverine at the San Francisco Zoo became the first of his kind to have a custom-made artificial lens implanted in his eye. Edward the wolverine had a cataract surgery ...
(BPT) - If you have diabetes, you're intimately aware that building an experienced care team is key to protecting your health. From establishing care with a knowledgeable primary care physician to ...
VIRGINIA BEACH, Va. (WAVY) — Animal Eye Care Associates announced they will be providing free eye exams for diabetic dogs during the entire month of November for Diabetes Awareness Month. According to ...
This article is part of “Innovations In: Type 1 Diabetes”, an editorially independent special report that was produced with financial support from Vertex. Sterling Glass had many health problems as a ...
WFS1 spectrum disorder (WFS1-SD) is a rare genetic condition, characterized by diabetes insipidus, diabetes mellitus, optic atrophy, and deafness (DIDMOAD) (1). Patients typically present with insulin ...
With the increasing prevalence of phacoemulsification surgery in our country, particularly refractive cataract surgery, patients have higher expectations for postoperative visual quality. However, ...
Millions of Americans will be diagnosed with cataracts in 2025, about three million of whom will undergo cataract replacement surgery annually. News 9 spoke to Dr. Ralph Hester from the Dean McGee Eye ...
EXN407 is the first topical SRPK1 inhibitor to demonstrate safety and efficacy as a monotherapy for non-proliferative diabetic retinopathy (NPDR) and diabetic macular oedema Phase IIb trial to ...
Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback